Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reck

Showing results (801-810 of 1,518) with videos related to

Pageof 152
Sort By:
Elife|December 9, 2021
Cytoplasmic dynein-1 cargo diversity is mediated by the combinatorial assembly of FTS-Hook-FHIP complexesJenna R Christensen, Agnieszka A Kendrick, Joey B Truong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2011
Safety and efficacy of first-line bevacizumab plus chemotherapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer: safety of avastin in lung trial (MO19390)Janessa Laskin, Lucio Crinò, Enriqueta Felip, et al.
Klinische Wochenschrift|August 1, 1975
Effect of propranolol and prindolol on renin secretion in normal supine manW Vetter, K Záruba, H Armbruster, et al.
Glycoconjugate Journal|June 1, 1994
Synthetic substrate analogues for UDP-GlcNAc: Man alpha 1-6R beta(1-2)-N-acetylglucosaminyltransferase II. Substrate specificity and inhibitors for the enzymeF Reck, E Meinjohanns, M Springer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2005
Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesotheliomaC Manegold, J Symanowski, U Gatzemeier, et al.
Lung Cancer (Amsterdam, Netherlands)|June 4, 2014
DISRUPT: a randomised phase 2 trial of ombrabulin (AVE8062) plus a taxane-platinum regimen as first-line therapy for metastatic non-small cell lung cancerJoachim von Pawel, Vera Gorbounova, Martin Reck, et al.
Sleep|March 31, 2023
Racial differences in upper airway collapsibility and loop gain in young adult malesShipra Puri, Gino S Panza, Dylan Kissane, et al.
Journal of Medicinal Chemistry|August 29, 2007
Novel substituted (pyridin-3-yl)phenyloxazolidinones: antibacterial agents with reduced activity against monoamine oxidase A and increased solubilityFolkert Reck, Fei Zhou, Charles J Eyermann, et al.
The European Journal of Neuroscience|February 4, 2009
Characterisation of tremor-associated local field potentials in the subthalamic nucleus in Parkinson's diseaseChristiane Reck, Esther Florin, Lars Wojtecki, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|November 13, 2020
Cutaneous Reactions to AluminumSara A Kullberg, Jordan M Ward, Yujie Linda Liou, et al.
Pageof 152

Showing results (801-810 of 1,518) with videos related to

Sort By:
Pageof 152
Elife|December 9, 2021
Cytoplasmic dynein-1 cargo diversity is mediated by the combinatorial assembly of FTS-Hook-FHIP complexesJenna R Christensen, Agnieszka A Kendrick, Joey B Truong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2011
Safety and efficacy of first-line bevacizumab plus chemotherapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer: safety of avastin in lung trial (MO19390)Janessa Laskin, Lucio Crinò, Enriqueta Felip, et al.
Klinische Wochenschrift|August 1, 1975
Effect of propranolol and prindolol on renin secretion in normal supine manW Vetter, K Záruba, H Armbruster, et al.
Glycoconjugate Journal|June 1, 1994
Synthetic substrate analogues for UDP-GlcNAc: Man alpha 1-6R beta(1-2)-N-acetylglucosaminyltransferase II. Substrate specificity and inhibitors for the enzymeF Reck, E Meinjohanns, M Springer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2005
Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesotheliomaC Manegold, J Symanowski, U Gatzemeier, et al.
Lung Cancer (Amsterdam, Netherlands)|June 4, 2014
DISRUPT: a randomised phase 2 trial of ombrabulin (AVE8062) plus a taxane-platinum regimen as first-line therapy for metastatic non-small cell lung cancerJoachim von Pawel, Vera Gorbounova, Martin Reck, et al.
Sleep|March 31, 2023
Racial differences in upper airway collapsibility and loop gain in young adult malesShipra Puri, Gino S Panza, Dylan Kissane, et al.
Journal of Medicinal Chemistry|August 29, 2007
Novel substituted (pyridin-3-yl)phenyloxazolidinones: antibacterial agents with reduced activity against monoamine oxidase A and increased solubilityFolkert Reck, Fei Zhou, Charles J Eyermann, et al.
The European Journal of Neuroscience|February 4, 2009
Characterisation of tremor-associated local field potentials in the subthalamic nucleus in Parkinson's diseaseChristiane Reck, Esther Florin, Lars Wojtecki, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|November 13, 2020
Cutaneous Reactions to AluminumSara A Kullberg, Jordan M Ward, Yujie Linda Liou, et al.
Pageof 152